These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28827249)
1. Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey. Ghanouni A; Renzi C; McBride E; Waller J BMJ Open; 2017 Aug; 7(8):e015955. PubMed ID: 28827249 [TBL] [Abstract][Full Text] [Related]
2. Improving public understanding of 'overdiagnosis' in England: a population survey assessing familiarity with possible terms for labelling the concept and perceptions of appropriate terminology. Ghanouni A; Renzi C; Waller J BMJ Open; 2018 Jun; 8(6):e021260. PubMed ID: 29950468 [TBL] [Abstract][Full Text] [Related]
3. A cross-sectional survey assessing factors associated with reading cancer screening information: previous screening behaviour, demographics and decision-making style. Ghanouni A; Renzi C; Waller J BMC Public Health; 2017 Apr; 17(1):327. PubMed ID: 28420378 [TBL] [Abstract][Full Text] [Related]
4. Survey of public definitions of the term 'overdiagnosis' in the UK. Ghanouni A; Meisel SF; Renzi C; Wardle J; Waller J BMJ Open; 2016 Apr; 6(4):e010723. PubMed ID: 27053274 [TBL] [Abstract][Full Text] [Related]
5. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Hoffman RM; Lewis CL; Pignone MP; Couper MP; Barry MJ; Elmore JG; Levin CA; Van Hoewyk J; Zikmund-Fisher BJ Med Decis Making; 2010; 30(5 Suppl):53S-64S. PubMed ID: 20881154 [TBL] [Abstract][Full Text] [Related]
6. U.S. women's perceived importance of the harms and benefits of mammograms and associations with screening ambivalence: Results from a national survey. Qin X; Nagler RH; Fowler EF; Gollust SE Prev Med; 2019 Jun; 123():130-137. PubMed ID: 30890352 [TBL] [Abstract][Full Text] [Related]
7. A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial. Sheridan SL; Sutkowi-Hemstreet A; Barclay C; Brewer NT; Dolor RJ; Gizlice Z; Lewis CL; Reuland DS; Golin CE; Kistler CE; Vu M; Harris R JAMA Intern Med; 2016 Jan; 176(1):31-41. PubMed ID: 26720730 [TBL] [Abstract][Full Text] [Related]
8. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study. Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309 [TBL] [Abstract][Full Text] [Related]
9. Responses to Overdiagnosis in Thyroid Cancer Screening among Korean Women. Lee S; Lee YY; Yoon HJ; Choi E; Suh M; Park B; Jun JK; Kim Y; Choi KS Cancer Res Treat; 2016 Jul; 48(3):883-91. PubMed ID: 26727718 [TBL] [Abstract][Full Text] [Related]
10. Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia. Pickles K; Scherer LD; Cvejic E; Hersch J; Barratt A; McCaffery KJ JAMA Netw Open; 2021 Oct; 4(10):e2128380. PubMed ID: 34636915 [TBL] [Abstract][Full Text] [Related]
12. Different Types of Patient Health Information Associated With Physician Decision-making Regarding Cancer Screening Cessation for Older Adults. Schoenborn NL; Boyd CM; Pollack CE JAMA Netw Open; 2023 May; 6(5):e2313367. PubMed ID: 37184836 [TBL] [Abstract][Full Text] [Related]
13. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey. Kobayashi LC; Waller J; von Wagner C; Wardle J BMC Public Health; 2016 Jul; 16():659. PubMed ID: 27473593 [TBL] [Abstract][Full Text] [Related]
14. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796 [TBL] [Abstract][Full Text] [Related]
15. Women's Awareness of and Responses to Messages About Breast Cancer Overdiagnosis and Overtreatment: Results From a 2016 National Survey. Nagler RH; Franklin Fowler E; Gollust SE Med Care; 2017 Oct; 55(10):879-885. PubMed ID: 28857962 [TBL] [Abstract][Full Text] [Related]
16. Preconceptions influence women's perceptions of information on breast cancer screening: a qualitative study. Henriksen MJ; Guassora AD; Brodersen J BMC Res Notes; 2015 Sep; 8():404. PubMed ID: 26336075 [TBL] [Abstract][Full Text] [Related]
17. What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians. Moynihan R; Nickel B; Hersch J; Doust J; Barratt A; Beller E; McCaffery K BMJ Open; 2015 May; 5(5):e007436. PubMed ID: 25991454 [TBL] [Abstract][Full Text] [Related]
18. Understanding the Harms and Benefits of Cancer Screening: A Model of Factors That Shape Informed Decision Making. Petrova D; Garcia-Retamero R; Cokely ET Med Decis Making; 2015 Oct; 35(7):847-58. PubMed ID: 26044208 [TBL] [Abstract][Full Text] [Related]
19. Public awareness of and responses to media coverage of invitation errors in the Breast Screening Programme in England: a cross-sectional population survey. Ghanouni A; von Wagner C; Waller J BMJ Open; 2019 Sep; 9(9):e028040. PubMed ID: 31494600 [TBL] [Abstract][Full Text] [Related]
20. Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects. Shamsutdinova A; Turdaliyeva B; Tanabayeva S; Omarova A; Saliev T; Tanabayev B; Fakhradiyev I Asian Pac J Cancer Prev; 2023 Jul; 24(7):2515-2522. PubMed ID: 37505786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]